REMUS PHARMACEUTICALS L Share Price

₹ 821.00

-₹22.35 (-2.65%)
1D
Last updated 02 Nov, 2026, 15:27 IST
NSE: REMUS
|
Trading

REMUS PHARMACEUTICALS L Share Price Today

As of 2 Nov 2026, REMUS PHARMACEUTICALS L share price is ₹821.00. The stock opened at ₹852.00, compared to its previous close of ₹843.35. During today's trading session, REMUS PHARMACEUTICALS L share price moved in the range of ₹821.00 to ₹872.95, with an average price of ₹846.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹580.00 and a high of ₹1,039.00. On the performance front, REMUS PHARMACEUTICALS L share price has increased by 23.06% over the last six months and is up 22.57% on a year-on-year basis.

Share price over the last 1 day fell from 852.00 to 821.00, ranging between 821.00 and 872.95.
₹821.00
2.65% down today
₹872.95
1D LOW
1D HIGH

REMUS PHARMACEUTICALS L Stock Insights

Stock Performance
OutperformingBeat Nifty by 22.59 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 48.56%
Shareholding Pattern
FIIFII decreased stake by 3.55%
REMUS PHARMACEUTICALS L stock performance
Open₹852.00
High₹872.95
Low₹821.00
Prev. close₹843.35
REMUS PHARMACEUTICALS L trading activity
Volume8,100
Average traded price₹841.42
Last traded time03:27:01 02 Nov
Last traded quantity100
Circuit
L
H
₹674.70
₹1,012.00
52-week
L
H
₹580.00
₹1,039.00
Mkt Cap Cr
993.80
P/E
20.0
P/B
2.11
ROA
8.9%
ROE
15.22%
ROCE
18.42%
Quick Ratio
1.49
EV/EBITDA
11.9

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Remus Pharma. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Remus Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Remus Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

REMUS PHARMACEUTICALS L Company Background

ISIN
INE0O5T01011
Sector Market Cap
₹ 993.80 Cr

Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.

REMUS PHARMACEUTICALS L Financial Highlights

  • Revenue: REMUS PHARMACEUTICALS L reported revenue of ₹860.33 crore in FY26 vs ₹625.34 crore in FY25. It showed an increase of 37.58% on a yearly basis.
  • Operating Profit: REMUS PHARMACEUTICALS L reported an operating profit of ₹59.16 crore in FY26 vs ₹47.34 crore in FY25. It showed an increase of 24.97% on a year-on-year basis.
  • Net Profit: REMUS PHARMACEUTICALS L reported a net profit of ₹46.17 crore in FY26 vs ₹38.42 crore in FY25. It showed an increase of 20.17% on a yearly basis.
Promoters
70.95%
FII
5.10%
Other DII
0.43%
Retail and other
23.52%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jul 20255.03%
Sep 20255.02%
Mar 20265.28%
Sep 20265.10%

REMUS PHARMACEUTICALS L Investment Returns

1 day
-3.48%
1 week
-4.23%
1 month
-6.63%
1 year
+22.57%
3 years
-85.04%
5 years
-53.06%

REMUS PHARMACEUTICALS L Share Price History

REMUS PHARMACEUTICALS L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹855.00 / ₹843.35
-3.48%
29 Oct 26
₹856.20 / ₹873.80
-0.06%
28 Oct 26
₹885.40 / ₹874.35
-0.69%
27 Oct 26
₹900.00 / ₹880.45
-1.33%
Show more

REMUS PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Revenue₹853.63₹620.36₹212.50
Other Income₹6.69₹4.98₹5.40
Total Revenue₹860.32₹625.34₹217.90
Total Expenses₹801.18₹578.00₹186.07
Profit Before Tax₹59.14₹47.34₹31.83
Tax₹12.97₹8.92₹5.85
Profit After Tax₹46.17₹38.42₹25.98
EPS - Basic₹39.19₹32.61₹152.01
EPS - Diluted₹39.19₹32.61₹152.01

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Profit before tax₹59.16₹47.34₹31.83
Income before WC changes₹61.30₹47.57₹31.05
Change in Assets-₹57.01-₹3.37-₹57.10
Change in Liabilities₹23.33-₹29.74₹36.22
Change in WC-₹33.68-₹33.11-₹20.88
Cash flow from Operations₹18.16₹6.98₹3.60
Cash flow from Investing-₹15.03-₹10.55-₹8.94
Cash flow from Financing₹1.47₹6.07₹24.37
Total Cash Flow₹4.60₹2.50₹19.03
Cash (Start of the year)₹7.22₹4.73₹7.84
Cash (End of the year)₹11.82₹7.23₹26.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Non-Current Assets₹284.01₹211.27₹47.53
Current Assets₹294.64₹221.37₹209.74
Total Assets₹578.65₹432.64₹257.27
Current Liabilities₹149.10₹121.53₹149.48
Net Current Asset₹145.54₹99.84₹60.26
Non-Current Liabilities₹41.82₹28.56₹3.46
Equity Capital₹387.73₹282.55₹104.33
Total Equity & Liabilities₹578.65₹432.64₹257.27

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹93.99₹79.16₹63.94₹45.03
Other Income₹6.84₹2.91₹2.81₹1.58
Total Revenue₹100.83₹82.07₹66.75₹46.60
Total Expenses₹67.60₹55.43₹44.40₹35.19
Profit Before Tax₹33.23₹26.64₹22.35₹11.41
Tax₹8.52₹6.74₹5.73₹2.91
Profit After Tax₹24.71₹19.90₹16.62₹8.50
EPS - Basic₹20.96₹16.88₹29.40₹83.24
EPS - Diluted₹20.96₹16.88₹29.40₹83.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹33.23₹26.64₹22.35₹11.41
Income before WC changes₹34.34₹26.69₹21.59₹11.58
Change in Assets-₹6.53-₹0.58-₹15.83-₹1.77
Change in Liabilities₹1.53-₹3.00₹6.80-₹1.51
Change in WC-₹5.00-₹3.58-₹9.03-₹3.27
Cash flow from Operations₹22.30₹15.59₹6.31₹5.31
Cash flow from Investing-₹26.33-₹12.42-₹47.24-₹15.19
Cash flow from Financing₹0.13-₹1.42₹41.63₹11.77
Total Cash Flow-₹3.90₹1.75₹0.70₹1.89
Cash (Start of the year)₹3.46₹1.71₹1.01₹1.15
Cash (End of the year)-₹0.44₹3.46₹1.71₹3.04

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹298.31₹226.40₹134.61₹23.32
Current Assets₹83.63₹53.91₹48.88₹11.34
Total Assets₹381.94₹280.31₹183.49₹34.66
Current Liabilities₹17.72₹11.08₹14.92₹8.16
Net Current Asset₹65.91₹42.83₹33.96₹3.18
Non-Current Liabilities₹38.51₹27.01₹15.02₹7.36
Equity Capital₹325.71₹242.22₹153.55₹19.14
Total Equity & Liabilities₹381.94₹280.31₹183.49₹34.66
* All values are in INR Crore
REMUS PHARMACEUTICALS L market depth
Bid quantityBid priceAsk priceAsk quantity
00831500
0000
0000
0000
0000
Total bid quantity0
Total ask quantity500
REMUS PHARMACEUTICALS L technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
39.17
Neutral
ATR (14)
42.68
Neutral
STOCH(9,6)
7.8
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
24.23
Bearish
UO(9)
43.66
Neutral
ROC(12)
-8.83
Bearish
WillR(14)
-93.66
Bullish
Period
Simple value
Exponential vaue
5D
872.85
871.86
10D
904.83
892.81
20D
916.13
908.54
50D
917.43
897.75
100D
843.2
854.84
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

REMUS PHARMACEUTICALS L
Trading
Add Stock
Add Another

REMUS PHARMACEUTICALS L Returns Calculator

Ex-date: 22 Sep 2026
Ex-date: 14 Nov 2025

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

REMUS PHARMACEUTICALS L Share Price FAQs

Please be aware that REMUS PHARMACEUTICALS L stock prices are subject to continuous fluctuations due to various factors.